2015 Q3 Form 10-Q Financial Statement

#000155335015000837 Filed on August 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $880.0K $430.0K $330.0K
YoY Change 109.52% 10.26% 0.0%
% of Gross Profit
Research & Development $1.050M $619.5K $900.0K
YoY Change 41.61% 0.17% 80.0%
% of Gross Profit
Depreciation & Amortization $41.34K $37.41K $40.00K
YoY Change 18.66% 10.47% 0.0%
% of Gross Profit
Operating Expenses $1.930M $1.052M $1.240M
YoY Change 66.28% 4.05% 47.62%
Operating Profit -$1.930M
YoY Change 66.27%
Interest Expense $0.00 $0.00
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$1.930M -$1.050M -$1.240M
YoY Change 64.96% 3.96% 47.62%
Income Tax
% Of Pretax Income
Net Earnings -$1.930M -$1.052M -$1.240M
YoY Change 64.3% 4.05% 47.62%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.03 -$0.02 -$0.02
COMMON SHARES
Basic Shares Outstanding 61.25M shares 58.42M shares 58.36M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.140M $2.920M $3.170M
YoY Change -49.17% -3.63% 39.65%
Cash & Equivalents $2.140M $2.920M $3.166M
Short-Term Investments
Other Short-Term Assets $220.0K $270.0K $130.0K
YoY Change 29.41% 35.0% 0.0%
Inventory
Prepaid Expenses $215.6K $267.1K $128.2K
Receivables
Other Receivables
Total Short-Term Assets $2.358M $3.187M $3.294M
YoY Change -46.24% -1.28% 37.09%
LONG-TERM ASSETS
Property, Plant & Equipment $510.3K $522.2K $375.2K
YoY Change 26.42% 59.92% 25.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.129M $1.135M $985.3K
YoY Change 12.17% 26.19% 17.03%
TOTAL ASSETS
Total Short-Term Assets $2.358M $3.187M $3.294M
Total Long-Term Assets $1.129M $1.135M $985.3K
Total Assets $3.486M $4.322M $4.279M
YoY Change -35.34% 4.71% 31.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $78.90K $78.19K $178.2K
YoY Change -76.04% -24.23% 172.38%
Accrued Expenses $72.18K $60.00K $33.35K
YoY Change -29.95% 84.0% 319.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $160.0K $150.0K $220.0K
YoY Change -68.0% -21.05% 83.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $160.0K $150.0K $220.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $163.0K $150.0K $221.8K
YoY Change -67.53% -21.2% 81.57%
SHAREHOLDERS EQUITY
Retained Earnings -$40.80M -$38.87M -$36.75M
YoY Change 14.88% 13.19% 13.63%
Common Stock $44.12M $43.04M $40.81M
YoY Change 9.2% 12.44% 15.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.323M $4.173M $4.058M
YoY Change
Total Liabilities & Shareholders Equity $3.486M $4.322M $4.279M
YoY Change -35.34% 4.71% 31.89%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q4
OPERATING ACTIVITIES
Net Income -$1.930M -$1.052M -$1.240M
YoY Change 64.3% 4.05% 47.62%
Depreciation, Depletion And Amortization $41.34K $37.41K $40.00K
YoY Change 18.66% 10.47% 0.0%
Cash From Operating Activities -$730.0K -$1.230M -$1.070M
YoY Change 28.07% 25.51% 22.99%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$100.0K -$20.00K
YoY Change -71.43% 150.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$40.00K -$100.0K -$20.00K
YoY Change -71.43% 150.0% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.920M 0.000
YoY Change -100.0% -9.43% -100.0%
NET CHANGE
Cash From Operating Activities -730.0K -1.230M -1.070M
Cash From Investing Activities -40.00K -100.0K -20.00K
Cash From Financing Activities 0.000 1.920M 0.000
Net Change In Cash -770.0K 590.0K -1.090M
YoY Change -162.6% -46.36% 211.43%
FREE CASH FLOW
Cash From Operating Activities -$730.0K -$1.230M -$1.070M
Capital Expenditures -$40.00K -$100.0K -$20.00K
Free Cash Flow -$690.0K -$1.130M -$1.050M
YoY Change 60.47% 20.21% 22.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Sales Revenue Net
SalesRevenueNet
2500 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1264698 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1203892 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1011309 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
58382 USD
CY2015Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
267054 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
3187406 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
522171 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
612848 USD
CY2015Q2 us-gaap Assets
Assets
4322425 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
78187 USD
CY2015Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
15672 USD
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
61248 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42983064 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38871656 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
4172656 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4322425 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3165940 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
128227 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3294167 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
375227 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
610029 USD
CY2014Q4 us-gaap Assets
Assets
4279423 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
178165 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
10323 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33353 USD
CY2014Q4 us-gaap Liabilities
Liabilities
221841 USD
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61247593 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58381854 shares
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40753189 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36753989 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
4057582 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-2117790 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1996473 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
123 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
124 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
392917 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1052338 USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58381854 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61247593 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2920352 USD
us-gaap Sales Revenue Net
SalesRevenueNet
USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4279423 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
853092 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
795081 USD
us-gaap Operating Expenses
OperatingExpenses
2117790 USD
us-gaap Operating Expenses
OperatingExpenses
1998973 USD
us-gaap Interest Expense
InterestExpense
USD
us-gaap Interest Expense
InterestExpense
2742 USD
us-gaap Net Income Loss
NetIncomeLoss
-2117667 USD
us-gaap Net Income Loss
NetIncomeLoss
-1999091 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58968556 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53123623 shares
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
619492 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
618454 USD
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
432846 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
1052338 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
1011371 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1052276 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
58949676 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40576 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
221511 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
55654 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1915000 USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
55654 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1011371 USD
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
62 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
62 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
759613 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2270704 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3030317 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1915000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2060000 USD
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53478623 shares
us-gaap Share Based Compensation
ShareBasedCompensation
221511 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
40576 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
81584 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
138827 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-99978 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
5349 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22557 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1929241 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10250 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
221097 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-231347 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
USD
lwlg Common Stock Issued To Institutional Investor Value
CommonStockIssuedToInstitutionalInvestorValue
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1915000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-245588 USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
72701 USD
us-gaap Share Based Compensation
ShareBasedCompensation
345189 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4742 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
71502 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66071 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
37783 USD
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
5732 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24660 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1502853 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36785 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
92239 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-129024 USD
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
153830 USD
lwlg Common Stock Issued To Institutional Investor Value
CommonStockIssuedToInstitutionalInvestorValue
177660 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2391490 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
376635 USD
us-gaap Nature Of Operations
NatureOfOperations
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt; font-family: 'times new roman', times;"><b>Nature of Business</b></font></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt; font-family: 'times new roman', times;">Lightwave Logic, Inc. is a technology Company focused on the development of next generation photonic devices and non-linear optical polymer materials systems for applications in high speed fiber-optic data communications and optical computing markets. Currently the Company is in various stages of photonic device and materials development and evaluation with potential customers and strategic partners. The Company expects the next revenue stream to be in sales of non-linear optical polymers, prototype devices and product development agreements prior to moving into production.</font></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0px; font-family: 'times new roman';"><font style="font-size: 10pt; font-family: 'times new roman', times;">The Company's current development activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company's technology now under development.</font></p> </div>
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
USD
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2015Q2 lwlg Approximate Cash Position
ApproximateCashPosition
2670000 USD
CY2014Q2 lwlg Expense For Abandoned Patents
ExpenseForAbandonedPatents
0 USD
lwlg Approximate Monthly Expenditures
ApproximateMonthlyExpenditures
275000 USD
lwlg Remaining Funds Available Under Agreement Guarantees And Other Commitments By Institutional Investor
RemainingFundsAvailableUnderAgreementGuaranteesAndOtherCommitmentsByInstitutionalInvestor
18485352 USD
lwlg Agreement With Institutional Investor Term
AgreementWithInstitutionalInvestorTerm
P30M
lwlg Proceeds From Issuance Of Private Placement Transaction One
ProceedsFromIssuanceOfPrivatePlacementTransactionOne
1915000 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
972958 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
751862 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
450787 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
50557 USD
us-gaap Depreciation
Depreciation
74153 USD
us-gaap Depreciation
Depreciation
64071 USD
CY2015Q2 us-gaap Depreciation
Depreciation
37407 USD
CY2014Q2 us-gaap Depreciation
Depreciation
33862 USD
lwlg Expense For Abandoned Patents
ExpenseForAbandonedPatents
0 USD
lwlg Expense For Abandoned Patents
ExpenseForAbandonedPatents
0 USD
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3716 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3716 USD
CY2015Q2 lwlg Expense For Abandoned Patents
ExpenseForAbandonedPatents
0 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7431 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7431 USD
CY2015Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
670835 USD
CY2014Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
660586 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
57987 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
lwlg Agreement To Sell Invest Common Stock Value Upper Limit Institutional Investor
AgreementToSellInvestCommonStockValueUpperLimitInstitutionalInvestor
20000000 USD
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';">Black-Scholes</div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.72 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.79 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0160 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0166 pure
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
228593 USD
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61247593 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
Lightwave Logic, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001325964
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q

Files In Submission

Name View Source Status
0001553350-15-000837-index-headers.html Edgar Link pending
0001553350-15-000837-index.html Edgar Link pending
0001553350-15-000837.txt Edgar Link pending
0001553350-15-000837-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lwlg-20150630.xml Edgar Link completed
lwlg-20150630.xsd Edgar Link pending
lwlg-20150630_cal.xml Edgar Link unprocessable
lwlg-20150630_def.xml Edgar Link unprocessable
lwlg-20150630_lab.xml Edgar Link unprocessable
lwlg-20150630_pre.xml Edgar Link unprocessable
lwlg_10q.htm Edgar Link pending
lwlg_10z1.htm Edgar Link pending
lwlg_ex31z1.htm Edgar Link pending
lwlg_ex31z2.htm Edgar Link pending
lwlg_ex32z1.htm Edgar Link pending
lwlg_ex32z2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending